tenofovir has been researched along with Non-alcoholic Fatty Liver Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaung, KT; Cheung, R; Henry, L; Hoang, JK; Le, AK; Li, J; Nguyen, MH | 1 |
| Gan, C; Han, Z; He, P; Huang, M; Ke, R; Lu, W; Luo, W; Shu, J; Xia, J; Xian, J; Xu, Z | 1 |
| Cotarelo, M; Macías, J; Mancebo, M; Merchante, N; Merino, D; Montes-Ramírez, ML; Pérez-Pérez, M; Pineda, JA; Pulido, F; Raffo, M; Rivero-Juárez, A; Téllez, F | 1 |
| Arslan, F; Batırel, A; Ceylan, B; Fersan, E; Fincancı, M; Mert, A; Paşaoğlu, E; Yardımcı, C; Yılmaz, M | 1 |
1 trial(s) available for tenofovir and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Body Mass Index; Body Weight; Cyclopropanes; Dideoxynucleosides; Drug Substitution; Drug Therapy, Combination; Elasticity Imaging Techniques; Emtricitabine; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Raltegravir Potassium; Tenofovir; Triglycerides; Waist-Hip Ratio | 2017 |
3 other study(ies) available for tenofovir and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Fatty liver is not independently associated with the rates of complete response to oral antiviral therapy in chronic hepatitis B patients.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Tenofovir | 2020 |
Association between Nonalcoholic Fatty Liver Disease and Bone Mineral Density in HIV-Infected Patients Receiving Long-term TDF-Based Antiretroviral Therapy.
Topics: Adult; Anti-HIV Agents; Bone Density; China; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Osteoporosis; Tenofovir | 2021 |
Impact of fatty liver on hepatitis B virus replication and virologic response to tenofovir and entecavir.
Topics: Adult; Age Factors; Aged; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lipoproteins, HDL; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Odds Ratio; Retrospective Studies; Tenofovir; Treatment Outcome; Virus Replication; Young Adult | 2016 |